The 20 Best Marginal Zone Lymphoma (MZL) Doctors Near Me in Ann Arbor, MI

Dr. Lauren Smith received her undergraduate degree at the University of Michigan Honors College with highest distinction in 1992. She spent four years working in a neurogenetics laboratory at the University of San Francisco with Dr. Nelson Freimer. For the next two years she worked as a manuscript editor for Dr. Donald Klein, a psychiatrist, at Columbia University. In 1998, she began medical school at the University of Michigan. She was awarded AOA in her junior year and was president of the UM AOA Chapter the following year. She completed her residency in anatomic/clinical pathology and fellowship in hematopathology from 2002-2007. In July, 2007 she began her faculty career as an Assistant Professor at the University of Michigan and was promoted to Associate Professor in 2013. She was appointed Fellowship Director in 2013. She was appointed the Director of the Ethics Path of Excellence in the University of Michigan Medical School in 2013. She became the permanent Director of the Hematopathology Section in 2016. In addition, she serves as a Hospital Ethicist at UMHS. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, T-Cell Lymphoma, Peripheral T-Cell Lymphoma, and Angioimmunoblastic T-cell Lymphoma.

Benjamin Viglianti is a Radiologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 17 years. Dr. Viglianti is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Osteopenia, Melorheostosis with Osteopoikilosis, and Melorheostosis. Dr. Viglianti is board certified in Diagnostic Radiology and Nuclear Medicine.

Mark Kaminski is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Kaminski is rated as a Distinguished provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Gastric Lymphoma, and Bone Marrow Aspiration.

Richard Brown is a Radiologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Brown is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Neuroendocrine Tumor, Mantle Cell Lymphoma (MCL), and Melorheostosis. Dr. Brown is board certified in Diagnostic Radiology, Nuclear Medicine, and Nuclear Radiology.

Dr. Tejasvi received his medical degree from Karnataka Institute of Medical Sciences, India. He completed residency-training program and worked as senior resident in Dermatology and Venereology, from All India Institute of Medical Sciences, New Delhi, India. He completed post-doctoral training in genetics of psoriasis under the direction of Drs. R.P.Nair and James T. Elder at the University of Michigan, Department of Dermatology in Ann Arbor.Dr. Tejasvi's primary research interest is translational genetics, epigenetics in psoriasis and pharmacogenetics that involves application of genetic information to predict response to therapies. Dr. Tejasvi is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.

Molly Roseland is a Radiologist practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 10 years. Dr. Roseland is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Melorheostosis with Osteopoikilosis, Melorheostosis, and Osteopenia. Dr. Roseland is board certified in Diagnostic Radiology and Nuclear Medicine.

Diana Gomez is a Radiologist and a Neuroradiologist practicing medicine in Ann Arbor, Michigan. Dr. Gomez is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Sciatica, Relapsing Multiple Sclerosis (RMS), Cerebellar Degeneration, and Meningioma. Dr. Gomez is board certified in Diagnostic Radiology and Neuroradiology.

Mishal Mendiratta is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Mendiratta is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 40 other conditions, according to our data. Her clinical expertise encompasses Liver Cancer, Fibrolamellar Carcinoma, Visceromegaly, and Cholangiocarcinoma (Bile Duct Cancer).

Smita Patel is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Secondary Immunodeficiency (SID), Rhabdomyosarcoma, Rhabdoid Tumor, and Synovial Sarcoma.

Ella Kazerooni is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Kazerooni is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 44 other conditions, according to our data. Her clinical expertise encompasses Lung Nodules, Emphysema, Interstitial Lung Disease, Pulmonary Fibrosis, and Transcatheter Aortic Valve Replacement (TAVR).

Joel Platt is a Radiologist practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 44 years. Dr. Platt is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Undifferentiated Pleomorphic Sarcoma, Synovial Sarcoma, Ureterocele, and Rhabdomyosarcoma Embryonal.

Hakan Demirci is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Demirci is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Retinoblastoma, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy.

Dr. Karimi is an Clinical Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Michigan. Dr. Karimi received her undergraduate degree from Johns Hopkins University, her medical degree from the University of Pennsylvania School of Medicine and went on to complete her internal medicine residency and chief residency at the University of Chicago. She completed her Hematology & Oncology fellowship at Stanford University before joining the lymphoma group at the University of Michigan Rogel Cancer Center.Her research focus is on conducting clinical trials in B cell lymphomas including diffuse large B cell lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, Hodgkin's lymphoma and CLL/SLL. Dr. Karimi is a member of the Non-Hodgkin Lymphoma Guidelines panel for the National Comprehensive Cancer Center Network (NCCN).Dr. Karimi finds joy in connecting with patients and families and is honored to be a part of their care team in their cancer journey. She has personal experience knowing how challenging it can be to navigate the decisions and treatments of indolent and aggressive lymphomas. Her goal is to provide meticulous and compassionate patient care while incorporating the most up to date understanding of the disease and latest advances in treatments to each patient's case.Outside of the hospital, Dr. Karimi enjoys cooking, yoga, and hiking in the national parks across America. Languages spoken: English, Spanish, Urdu, Gujarati. Dr. Karimi is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), and Bone Marrow Aspiration. Dr. Karimi is board certified in Internal Medicine, Hematology, and Medical Oncology.

I ride both a road bike and Peleton. I golf about 2-3 times per week. Have four grandchildren to dote on. I mostly fiction novels. Exercise twice per week. Dr. Terebelo is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Essential Thrombocythemia, Familial Colorectal Cancer, Bone Marrow Aspiration, and Tissue Biopsy.

The T-cell lymphomas are a heterogeneous and poorly understood group of non-Hodgkin’s lymphomas. The most common T-cell lymphoma in the United States includes a heterogeneous mix of lymphomas that lack distinguishing characteristics and, until recently, remained clinically and molecularly “unspecified”. Improved understanding of T-cell lymphoma pathogenesis and the development of novel therapeutic strategies will be needed to address this challenge and improve outcomes for patients afflicted with these aggressive lymphomas. My group made the landmark discovery that the most common T-cell lymphoma in North America is comprised of two molecularly and clinically distinct subsets. This finding has significant implications for the classification and treatment of these lymphomas. We have also demonstrated that malignant T cells remain dependent upon antigen-presenting cells within the tumor microenvironment and are developing novel therapeutic strategies targeting these cells. Many fundamental questions, including the “cell of origin”, the role of antigen-, costimulatory-, and cytokine-receptor signaling, and the contribution of myeloid-derived antigen-presenting cells in disease pathogenesis remain obscure. My laboratory uses complementary mouse models and primary T-cell lymphoma specimens (in ex vivo and patient-derived xenograft studies) to address these fundamental and clinically relevant questions. We are poised to clinically translate our laboratory-based findings into novel therapeutic strategies that we hope will improve outcomes for patients afflicted with these aggressive lymphomas. I enjoy working with a multidisciplinary team of enthusiastic collaborators who share this common goal. Dr. Wilcox is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Wilcox is board certified in Internal Medicine, Hematology, and Medical Oncology.

Dr. Carty completed her undergraduate work at Harvard University, graduating magna cum laude, with a degree in Biochemical Sciences. She attended the Albert Einstein College of Medicine in New York where she earned her MD degree. Dr. Carty stayed in New York for her internal medicine residency at Columbia University Medical Center, and moved to the Hospital of the University of Pennsylvania for her Hematology-Oncology fellowship. She remained on staff at the Hospital of the University of Pennsylvania before moving here to Ann Arbor. Dr. Carty is the recipient of a K08 Award for her work in T cell biology and ASH Scholar Award for her research on T cell lymphomas. Dr. Carty is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration. Dr. Carty is board certified in Hematology.

Dr. Cuneo grew up in Northern California. He studied Biological and Environmental Engineering at Cornell University in Ithaca, NY. Dr. Cuneo received his Doctor of Medicine degree from Vanderbilt University School of Medicine in 2007 and completed an internship there in 2008. In 2008 he started his residency in Radiation Oncology at Duke University Medical Center. Dr. Cuneo has been an Assistant Professor in the Department of Radiation Oncology at the University of Michigan since 2012. Dr. Cuneo is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Pancreatic Cancer, Liposarcoma, Liver Cancer, and Pancreaticoduodenectomy. Dr. Cuneo is board certified in Radiation Oncology.

Erica Campagnaro is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Campagnaro is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Campagnaro is board certified in Internal Medicine and Hematology.

Kirk Frey is a Neurologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Frey is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Neuroendocrine Tumor, Osteopenia, and Hormone Replacement Therapy (HRT).

Prasad Shankar is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Shankar is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses WT1-Related Wilms Tumor Syndromes, Visceromegaly, Neuroendocrine Tumor, Renal Cell Carcinoma (RCC), and Prostatectomy.